In the early RA group compared with disease controls, only the RF comparison group and the RF combined with the anti-RA33 group demonstrated to have substantial increases in sensitivity and only a modest decrease in specificity with the additions of PCT and CT. The gene discussed is CALCA; the disease is rheumatoid arthritis.